−0.1833USD
−5.17 MUSD
24.64 M
About Cell Source, Inc.
Sector
Industry
CEO
Itamar Shimrat
Website
Headquarters
New York
Founded
2012
ISIN
US15114L1044
FIGI
BBG0046WCTF1
Cell Source, Inc. operates as a cell therapy company focused on immunotherapy. Its Veto Cell technology is a next generation immunotherapy technology that enables the selective attenuation of the immune system. The company's Veto Cell platform roadmap consists of two main programs: VETO CAR-T (with and without HSCT) and Veto Cell Organ Transplantation. The company was founded on June 6, 2012 and is headquartered in New York, NY.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CLCS is 0.3980 USD — it has increased by 0.13% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Cell Source, Inc. stocks are traded under the ticker CLCS.
CLCS stock is 13.71% volatile and has beta coefficient of 482.13. Check out the list of the most volatile stocks — is Cell Source, Inc. there?
Yes, you can track Cell Source, Inc. financials in yearly and quarterly reports right on TradingView.
CLCS stock has risen by 59.20% compared to the previous week, the month change is a 59.20% rise, over the last year Cell Source, Inc. has showed a 20.40% decrease.
CLCS net income for the last quarter is −1.34 M USD, while the quarter before that showed −1.24 M USD of net income which accounts for −7.77% change. Track more Cell Source, Inc. financial stats to get the full picture.
Today Cell Source, Inc. has the market capitalization of 15.34 M, it has decreased by 9.09% over the last week.
No, CLCS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CLCS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cell Source, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cell Source, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cell Source, Inc. stock shows the neutral signal. See more of Cell Source, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.